Clinical trials: sponsored by University Hospital, Brest

Coronary Heart Disease

Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel

• Completed
• Age: 18 to 85 years
• Phase 3

Objectives: A prospective investigation of the effect of omeprazole, a proton pump inhibitor, on the anti-platelet action of clopidogrel.

Trial name

NCT00349661

Testing

impact on VASP test

Where

France

Volunteers

120 people

Sponsor

University Hospital, Brest